1

Faes Farma

#4736

Rank

$1.53B

Marketcap

ES Spain

Country

Faes Farma
Leadership team

Mr. Mariano Ucar Angulo (Chairman of Directors)

Mr. Gonzalo Fernández de Valderrama Iribarnegaray (Sec. of the Board of Directors)

Products/ Services
Health Care, Manufacturing, Pharmaceutical
Number of Employees
1,000 - 20,000
Headquarters
Spain, Georgia, United States
Established
1933
Net Income
100M - 500M
Revenue
100M - 500M
Traded as
FAE.MC
Social Media
Overview
Location
Summary
Faes Farma, S.A., a pharmaceutical company, researches, develops, produces, and commercializes pharmaceutical products and raw materials in Spain and internationally. The company's product portfolio includes prescription drugs, generic drugs, over-the-counter (OTC) drugs, food supplements, baby foods, and other health products. It offers Actimag, a magnesium pidolate; Bilaxten, an anti-allergic; Bronquidiazina CR, an anti-infective; Claversal for ulcerative colitis and Crohn's disease; Dezacor, a corticoid; Dolotren, an anti-inflammatory; Dolotren Gel; Dynamogen, an anti-anorexic; Ferroprotina, an anti-anaemic; Hidroferol; Lipofen; Positon for dermatitis; strength builder products, such as Potenciator and Surmenalit; Pruina, a laxative; Robaxisal Compuesto, a muscle relaxant and analgesic; Trausan, a citicoline; Venosmil, a venous vasoprotector; Venosmil Gel; and Yendol, an anti-flu. The company also provides Bilastine, an antihistamine molecule for the treatment of allergic rhino conjunctivitis and urticarial; Calcifediol for bone metabolism; Deflazacort to treat osteoarticular disease; Hidrosmin for venous insufficiency; and Mesalazine to treat digestion problems. It also exports its products. Faes Farma, S.A. was founded in 1933 and is headquartered in Leioa, Spain.
History

Faes Farma began as a small family business in Barcelona. Over the years, the company has grown into one of the most prestigious and innovative pharmaceutical companies in Spain. Throughout the years, Faes Farma has invested in research and development, enabling it to develop and launch innovative products, such as its 10XR line of low-intensity radiopharmaceutical products.

Mission
Our mission at Faes Farma is to create innovative and sustainable products, and to provide high-quality healthcare solutions with a focus on patients’ needs and well-being.
Vision
We strive to be a leading player in the pharmaceutical sector, providing high-quality and innovative products and services in order to contribute to the well-being of society.
Key Team

Mr. Mariano Ucar Angulo (Chairman of Directors)

Mr. Gonzalo Fernández de Valderrama Iribarnegaray (Sec. of the Board of Directors)

Recognition and Awards
Faes Farma has received numerous awards and recognition for its commitment to innovation, quality, and sustainability. In 2017, the company was named one of the Top 25 Pharmaceutical Companies in Spain. The company has also been recognized with several awards, such as the Corporate Technology Award and the Best Pharmaceutical Business Award.
References

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Faes Farma
Leadership team

Mr. Mariano Ucar Angulo (Chairman of Directors)

Mr. Gonzalo Fernández de Valderrama Iribarnegaray (Sec. of the Board of Directors)

Products/ Services
Health Care, Manufacturing, Pharmaceutical
Number of Employees
1,000 - 20,000
Headquarters
Spain, Georgia, United States
Established
1933
Net Income
100M - 500M
Revenue
100M - 500M
Traded as
FAE.MC
Social Media